CD34 and acute myeloid leukemia: In the context of AML, a genome-wide analysis of aberrant AS patterns showed that approximately one third of genes are differentially spliced in the primitive CD34+ cells of AML patients compared to those obtained from normal controls, suggesting that such genes are involved in processes key to cellular function14.